Immunotherapy, Chemotherapy, Radiotherapy and Surgery for Synchronous Oligo-metastatic NSCLC
Clinical trial NCT03965468 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03965468
- Sponsor
- ETOP IBCSG Partners Foundation
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-19
- Primary completion
- 2026-08-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.